Houston, TX, United States of America

Daniel James Catanese, Jr

This inventor holds 4 USPTO granted patents and 7 published patent applications. Top assignees: Baylor College of Medicine, Twister Biotech, Inc.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel James Catanese, Jr. Retrieved from https://idiyas.com/inventor/daniel-james-catanese-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 1


Company Filing History:


Years Active: 2013-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Daniel James Catanese, Jr.

Introduction

Daniel James Catanese, Jr. is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of gene therapy, holding a total of 4 patents. His work focuses on innovative compositions and methods that have the potential to treat various diseases.

Latest Patents

Catanese's latest patents include the development of P53, P63, and P73 homo-tetrameric compositions. These compositions involve proteins that are truncated at or around the tetramerization domain and fused to a heterologous tetramerization domain from non-human sources. This innovation allows for the activity of the original proteins while preventing unwanted interactions within the cell. Additionally, he has developed supercoiled minicircle DNA for gene therapy applications, which comprises minivectors encoding nucleic acid sequences. This advancement enhances the methods of gene therapy, providing new avenues for treatment.

Career Highlights

Throughout his career, Catanese has worked with esteemed institutions such as Baylor College of Medicine and Twister Biotech, Inc. His research has been pivotal in advancing the understanding and application of gene therapy.

Collaborations

Catanese has collaborated with notable individuals in his field, including E Lynn Zechiedrich and Jonathan Fogg. These partnerships have contributed to the success and impact of his innovations.

Conclusion

Daniel James Catanese, Jr. is a prominent figure in the realm of gene therapy, with a focus on innovative solutions for treating diseases. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…